itepekimab
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for itepekimab, covering 2024-09-19 to 2026-06-02. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps [Phase 3]